|
End-of-day quote
Toronto S.E.
01:29:45 19/03/2019 am IST
|
5-day change | 1st Jan Change | ||
| 1.880 CAD | +1.62% |
|
+1.62% | +106.59% |
| 15/19/15 | Emblem Corp. Reports Earnings Results for the Full Year Ended December 31, 2018 | CI |
| 19/19/19 | Emblem Corp.(TSXV:EMC) dropped from S&P/TSX Venture Composite Index | CI |
| Market Cap | 25Cr 21Cr 20Cr 18Cr 35Cr 2.37TCr 35Cr 238.04Cr 93Cr 1.2TCr 93Cr 91Cr 3.97TCr | P/E 2017 |
-16.3x | P/E 2018 | -4.48x |
|---|---|---|---|---|---|
| Enterprise Value | 22Cr 19Cr 18Cr 16Cr 30Cr 2.1TCr 31Cr 210.19Cr 82Cr 1.06TCr 82Cr 81Cr 3.51TCr | EV / Sales 2017 |
7,23,52,077x | EV / Sales 2018 | 1,09,15,686x |
| Free-Float |
98.36% | Yield 2017 * |
-
| Yield 2018 | - |
| 1 day | +1.62% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tricia Symmes
CEO | Chief Executive Officer | - | - |
Nick Dean
CEO | Chief Executive Officer | - | 01/12/2017 |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
John H. Stewart
BRD | Director/Board Member | - | - |
Jeffrey Fineberg
BRD | Director/Board Member | - | - |
Terry Johnson
BRD | Director/Board Member | - | 06/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.62% | +1.62% | - | - | 0 | |
| +0.02% | +1.36% | -12.54% | -5.59% | 1.33TCr | |
| +0.53% | +2.99% | -32.15% | -56.36% | 499.01Cr | |
| +0.27% | +1.59% | -3.46% | +0.53% | 465.93Cr | |
| -0.43% | -1.64% | -0.25% | -29.65% | 401.78Cr | |
| +0.08% | +3.06% | -17.20% | +7.02% | 359.48Cr | |
| -0.67% | +2.71% | -2.91% | -3.69% | 343.15Cr | |
| +0.47% | -0.53% | -10.57% | +8.77% | 330.63Cr | |
| -2.19% | -2.26% | -24.23% | -12.67% | 237.78Cr | |
| +0.74% | +2.97% | -26.68% | -9.75% | 172.3Cr | |
| Average | +0.04% | +1.88% | -14.44% | -11.27% | 413.6Cr | |
| Weighted average by Cap. | -0.05% | +1.73% | -13.40% | -11.54% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 2.69 2.32 2.18 1.99 3.74 257.48 3.75 25.82 10.08 129.97 10.11 9.89 430.97 | 8.22 7.09 6.64 6.06 11.42 785.91 11.46 78.82 30.75 396.72 30.87 30.2 1.32T |
| Net income | -1.21Cr -1.04Cr -97.77L -89.25L -1.68Cr -115.65Cr -1.69Cr -12Cr -4.53Cr -58Cr -4.54Cr -4.44Cr -193.58Cr | -2.43Cr -2.09Cr -1.96Cr -1.79Cr -3.37Cr -231.85Cr -3.38Cr -23Cr -9.07Cr -117.04Cr -9.11Cr -8.91Cr -388.08Cr |
| Net Debt | -2.15Cr -1.85Cr -1.74Cr -1.59Cr -2.99Cr -205.6Cr -3Cr -21Cr -8.05Cr -103.79Cr -8.08Cr -7.9Cr -344.13Cr | -2.91Cr -2.5Cr -2.35Cr -2.14Cr -4.04Cr -277.67Cr -4.05Cr -28Cr -11Cr -140.17Cr -11Cr -11Cr -464.77Cr |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- EMC Stock
Select your edition
All financial news and data tailored to specific country editions
